Page last updated: 2024-11-05

tripelennamine and Hemolysis

tripelennamine has been researched along with Hemolysis in 3 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CARRYER, HM1
CODE, CF1
Ooi, YM1
Sheppard, H1
Tsien, WH1
Burghardt, C1

Other Studies

3 other studies available for tripelennamine and Hemolysis

ArticleYear
The effect of tripelennamine hydrochloride (pyribenzamine) on the release of histamine during in vitro hemolytic reaction in rabbit blood.
    The Journal of allergy, 1950, Volume: 21, Issue:4

    Topics: Animals; Blood; Hemolysis; Histamine; Humans; In Vitro Techniques; Patient Discharge; Rabbits; Tripe

1950
Histamine suppresses in vitro synthesis of precursor (pro-C5) of the fifth complement component (C5) by mouse peritoneal macrophages.
    Journal of immunology (Baltimore, Md. : 1950), 1982, Volume: 129, Issue:1

    Topics: Animals; Antigens; Bucladesine; Cimetidine; Complement C5; Complement Inactivator Proteins; Dimaprit

1982
Effect of drugs on the hemolysis of rat erythrocytes.
    Biochemical pharmacology, 1969, Volume: 18, Issue:9

    Topics: Animals; Aspirin; Bile Acids and Salts; Chlordiazepoxide; Chloroquine; Chlorpromazine; Chlorprothixe

1969